Skip to main content
. 2018 Mar 5;98(5):1435–1443. doi: 10.4269/ajtmh.17-0627

Figure 1.

Figure 1.

Disposition of study participants and reasons for exclusion from ATP cohort for immunogenicity. ATP = according-to-protocol; M13 = 12 months after dose 2; N = number of subjects in each group/cohort; * Withdrawals.